These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases]. Japan Atherosclerosis Society J Atheroscler Thromb; 2007 Apr; ():5-57. PubMed ID: 17566346 [No Abstract] [Full Text] [Related]
8. Intrauterine growth, the vascular system, and the metabolic syndrome. Holt RI; Byrne CD Semin Vasc Med; 2002 Feb; 2(1):33-43. PubMed ID: 16222594 [TBL] [Abstract][Full Text] [Related]
9. [Role of high blood pressure in progression of atherosclerosis in the metabolic syndrome]. Rakugi H; Ogihara T Nihon Rinsho; 2006 Dec; 64 Suppl 9():364-9. PubMed ID: 17458247 [No Abstract] [Full Text] [Related]
10. Periodontal disease as part of the insulin resistance syndrome in diabetic patients. Nishimura F; Soga Y; Iwamoto Y; Kudo C; Murayama Y J Int Acad Periodontol; 2005 Jan; 7(1):16-20. PubMed ID: 15736891 [TBL] [Abstract][Full Text] [Related]
12. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Wong TY; Duncan BB; Golden SH; Klein R; Couper DJ; Klein BE; Hubbard LD; Sharrett AR; Schmidt MI Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2949-54. PubMed ID: 15326106 [TBL] [Abstract][Full Text] [Related]
13. PPAR agonists in the treatment of insulin resistance and associated arterial disease. Camejo G Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596 [TBL] [Abstract][Full Text] [Related]
14. Genetic basis of atherosclerosis: part I: new genes and pathways. Lusis AJ; Fogelman AM; Fonarow GC Circulation; 2004 Sep; 110(13):1868-73. PubMed ID: 15451808 [No Abstract] [Full Text] [Related]
16. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Prasad A; Quyyumi AA Circulation; 2004 Sep; 110(11):1507-12. PubMed ID: 15364819 [No Abstract] [Full Text] [Related]
17. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. Hjortnaes J; Algra A; Olijhoek J; Huisman M; Jacobs J; van der Graaf Y; Visseren F J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269 [TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Olijhoek JK; van der Graaf Y; Banga JD; Algra A; Rabelink TJ; Visseren FL; Eur Heart J; 2004 Feb; 25(4):342-8. PubMed ID: 14984924 [TBL] [Abstract][Full Text] [Related]
19. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698 [TBL] [Abstract][Full Text] [Related]
20. Aging of progenitor cells contributes to atherosclerosis. SoRelle R Circulation; 2003 Jul; 108(4):e9006-7. PubMed ID: 12885741 [No Abstract] [Full Text] [Related] [Next] [New Search]